September 19, 2023
As New York Gov. Kathy Hochul announced a new initiative to explore state-level policies for combating the affordable housing crisis, Carl H. Lindner College of Business real estate professor Gary Painter, PhD, offered insight to Newsday on the impact of such programs.
September 19, 2023
Study abroad is back to 75% of pre-COVID levels at the University of Cincinnati, and a wide variety of international study options is available to students in any program. Where do you see yourself in the world?
September 18, 2023
Patient Reverend Michael Bailey and University of Cincinnati Cancer Center member Nilesh Patil spoke with WCPO about the importance of screening during Prostate Cancer Awareness Month.
September 15, 2023
Yahoo News published a story asking infectious disease experts if COVID-19 was transitioning into the endemic stage. One of the experts cited was Dr. Carl Fichtenbaum of the Division of Infectious Diseases at the UC College of Medicine.
September 15, 2023
It's now official. The University of Cincinnati enrolled 50,921 students for the fall semester. Growth has been continuous with the student body increasing by 19% during the past decade.
September 15, 2023
The United Auto Workers are launching a “targeted” strike, which could cause new and used car prices to significantly increase, a University of Cincinnati economist told WLWT.
September 15, 2023
Spectrum News recently highlighted the work of the UC Health mobile stroke unit that brings stroke care to patients faster and helped treat local patient Don Mundy.
September 14, 2023
BBC News Brazil recently highlighted the harm reduction vending machine program run by Cincinnati nonprofit Caracole in partnership with the University of Cincinnati.
September 14, 2023
Political scientist David Niven quoted for his opinion in WVXU article on Ohio's redistricting process. Niven is an associated professor in UC's School of Public and International Affairs and is often cited in media for his expertise on governmental affairs.
September 13, 2023
The FDA approved and authorized new COVID-19 and booster shots from Moderna and Pfizer, as cases of the coronavirus have risen nationwide over the past few weeks. A CDC panel of outside vaccine advisers then voted by a wide majority to back new shots retargeted for newer variants ahead of the fall virus season. WLWT-TV interviewed Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine.